ArticleHuman gene therapy2023

Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease.

Bishnu P De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.